R J Fass|V L Helsel - JoVE Visualize

Showing results (101-110 of 108) with videos related to

Pageof 11

Sort By:

You have reached the last page of results.This site can display upto 108 results.

Journal of Clinical and Experimental Neuropsychology|October 1, 1994

Neuropsychological performance and CD4 levels in HIV-1 asymptomatic infectionA M Podraza, R A Bornstein, C C Whitacre, et al.

The American Journal of the Medical Sciences|May 1, 1976

Tobramycin: in vitro and clinical evaluation in 30 patientsR L Perkins, S Saslaw, R J Fass, et al.

Journal of Clinical Microbiology|June 1, 1985

Ciprofloxacin disk susceptibility tests: interpretive zone size standards for 5-microgram disksA L Barry, R J Fass, J P Anhalt, et al.

The New England Journal of Medicine|December 24, 1992

A controlled trial of trimethoprim-sulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trials Group Protocol 021W D Hardy, J Feinberg, D M Finkelstein, et al.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 1, 1994

Clindamycin and primaquine therapy for mild-to-moderate episodes of Pneumocystis carinii pneumonia in patients with AIDS: AIDS Clinical Trials Group 044J R Black, J Feinberg, R L Murphy, et al.

Journal of Acquired Immune Deficiency Syndromes|February 1, 1994

The safety and efficacy of combination N-butyl-deoxynojirimycin (SC-48334) and zidovudine in patients with HIV-1 infection and 200-500 CD4 cells/mm3M A Fischl, L Resnick, R Coombs, et al.

AIDS (London, England)|August 16, 2001

A prospective study of discontinuing primary and secondary Pneumocystis carinii pneumonia prophylaxis after CD4 cell count increase to > 200 x 106 /lS L Koletar, A E Heald, D Finkelstein, et al.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 26, 2000

Paromomycin: no more effective than placebo for treatment of cryptosporidiosis in patients with advanced human immunodeficiency virus infection. AIDS Clinical Trial GroupR G Hewitt, C T Yiannoutsos, E S Higgs, et al.

Pageof 11

Showing results (101-110 of 108) with videos related to

Sort By:

Pageof 11

You have reached the last page of results.This site can display upto 108 results.

Journal of Clinical and Experimental Neuropsychology|October 1, 1994

Neuropsychological performance and CD4 levels in HIV-1 asymptomatic infectionA M Podraza, R A Bornstein, C C Whitacre, et al.

The American Journal of the Medical Sciences|May 1, 1976

Tobramycin: in vitro and clinical evaluation in 30 patientsR L Perkins, S Saslaw, R J Fass, et al.

Journal of Clinical Microbiology|June 1, 1985

Ciprofloxacin disk susceptibility tests: interpretive zone size standards for 5-microgram disksA L Barry, R J Fass, J P Anhalt, et al.

The New England Journal of Medicine|December 24, 1992

A controlled trial of trimethoprim-sulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trials Group Protocol 021W D Hardy, J Feinberg, D M Finkelstein, et al.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 1, 1994

Clindamycin and primaquine therapy for mild-to-moderate episodes of Pneumocystis carinii pneumonia in patients with AIDS: AIDS Clinical Trials Group 044J R Black, J Feinberg, R L Murphy, et al.

Journal of Acquired Immune Deficiency Syndromes|February 1, 1994

The safety and efficacy of combination N-butyl-deoxynojirimycin (SC-48334) and zidovudine in patients with HIV-1 infection and 200-500 CD4 cells/mm3M A Fischl, L Resnick, R Coombs, et al.

AIDS (London, England)|August 16, 2001

A prospective study of discontinuing primary and secondary Pneumocystis carinii pneumonia prophylaxis after CD4 cell count increase to > 200 x 106 /lS L Koletar, A E Heald, D Finkelstein, et al.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 26, 2000

Paromomycin: no more effective than placebo for treatment of cryptosporidiosis in patients with advanced human immunodeficiency virus infection. AIDS Clinical Trial GroupR G Hewitt, C T Yiannoutsos, E S Higgs, et al.

Pageof 11